CDNA 240920 30.00C (CDNA240920C30000) Stock Options, News & Quotes

0.63
-0.27-30.00%

15min DelayClose Sep 9 16:00 ET

0.63High0.63Low

SymbolStock Name

Latest PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry

WatchlistPaper Trade

Comments

Moomoo AI

Feb 14 04:36

Investors may believe CareDx's strong revenue growth is not imminent, leading to a low P/S ratio. Expected future revenue decline could further decrease the P/S ratio, making a significant stock price rise unlikely.

Little Excitement Around CareDx, Inc's (NASDAQ:CDNA) Revenues As Shares Take 28% Pounding

Moomoo AI

Dec 27, 2023 06:12

Despite a strong price move, CareDx's P/S ratio still trails the industry. The low P/S is due to the forecast for sliding revenue. Without significant change, drastic rise in the stock is unlikely.

CareDx, Inc (NASDAQ:CDNA) Surges 26% Yet Its Low P/S Is No Reason For Excitement

Meticulous Trader

Nov 17, 2023 11:54

$CareDx (CDNA.US)$ 4.80 missed and ran 📈👀

Trytosaveabit

Nov 9, 2023 07:44

Nice!

$CareDx (CDNA.US)$ Needs more volume! Looks like some MR at 8.25/8.50

Trytosaveabit

Nov 8, 2023 18:58

On watch for tomorrow!

$CareDx (CDNA.US)$ Check out these highlights! ((. Reported revenue of $67.2 million, an increase of 7% over the second
quarter of 2023, excluding approximately $7.8 million related to Medicare
claims billing that were held over from the first quarter of 2023 and
recognized in second quarter 2023 revenue.
-- Grew Testing Services patient results to 38,400, an increase of 2%
compared to the second quarter of 2023.
-- Achieved revenue of $9.9 million for Digital Solut...

Weight-loss drugmakers report strong earnings: Boon or bane?